Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
LP-659 by Longboard Pharmaceuticals for Neuroinflammation: Likelihood of Approval
LP-659 is under clinical development by Longboard Pharmaceuticals and currently in Phase I for Neuroinflammation. According to GlobalData, Phase I...